Yesintek^® Patient Transition Program Terms & Conditions 

The Yesintek Patient Transition Program provides a one-time Health Debit Card to patients who transition from Stelara or another Ustekinumab medicine to Yesintek, in the form of a $250 virtual debit card or check that the patient must certify will be used for healthcare related expenses. The following are acceptable merchant codes at which the debit cards can be used: 5912 drug stores, pharmacies, 8011 doctors – not elsewhere classified, 8050 nursing and personal care facilities, 8062 hospitals, 8071 dental and medical laboratories, and 8099 health practitioners/med SVCS unclassified. To qualify, a patient must provide proof of a filled Yesintek prescription for an approved indication dated no more than 90 days prior to applying for the Patient Transition Program. Residents of Illinois, Massachusetts, Michigan, Minnesota, Mississippi, and Rhode Island are not eligible. A patient is not eligible if the patient’s prescription is paid for , in whole or in part, by any state or federally funded programs, including but not limited to Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, or TRICARE, or private indemnity, or HMO insurance plans that reimburse the patient for the entire cost of the patient’s prescription drugs, or where prohibited by law. Biocon reserves the right to rescind, revoke, or amend this offer at any time and without further notice.